<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2008-02-05" modified="2018-01-31" version="121">
<accession>Q8IV16</accession>
<accession>Q6P3T2</accession>
<accession>Q86W15</accession>
<name>HDBP1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1</fullName>
<shortName>GPI-HBP1</shortName>
<shortName>GPI-anchored HDL-binding protein 1</shortName>
</recommendedName>
<alternativeName>
<fullName>High density lipoprotein-binding protein 1</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">GPIHBP1</name>
<name type="synonym">HBP1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="submission" date="2003-02" db="EMBL/GenBank/DDBJ databases">
<title>Isolation and characterization of human HBP1 gene.</title>
<authorList>
<person name="Shan Y.X."/>
<person name="Yu L."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="2">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<scope>VARIANT PHE-14</scope>
<source>
<tissue>Brain</tissue>
<tissue>PNS</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2007" name="Biochim. Biophys. Acta" volume="1771" first="1464" last="1468">
<title>Normal binding of lipoprotein lipase, chylomicrons, and apo-AV to GPIHBP1 containing a G56R amino acid substitution.</title>
<authorList>
<person name="Gin P."/>
<person name="Beigneux A.P."/>
<person name="Davies B."/>
<person name="Young M.F."/>
<person name="Ryan R.O."/>
<person name="Bensadoun A."/>
<person name="Fong L.G."/>
<person name="Young S.G."/>
</authorList>
<dbReference type="PubMed" id="17997385"/>
<dbReference type="DOI" id="10.1016/j.bbalip.2007.10.005"/>
</citation>
<scope>INTERACTION WITH APOA5 AND LPL</scope>
<scope>CHARACTERIZATION OF VARIANT ARG-56</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2011" name="J. Lipid Res." volume="52" first="1869" last="1884">
<title>GPIHBP1, an endothelial cell transporter for lipoprotein lipase.</title>
<authorList>
<person name="Young S.G."/>
<person name="Davies B.S."/>
<person name="Voss C.V."/>
<person name="Gin P."/>
<person name="Weinstein M.M."/>
<person name="Tontonoz P."/>
<person name="Reue K."/>
<person name="Bensadoun A."/>
<person name="Fong L.G."/>
<person name="Beigneux A.P."/>
</authorList>
<dbReference type="PubMed" id="21844202"/>
<dbReference type="DOI" id="10.1194/jlr.R018689"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2007" name="Lipids Health Dis." volume="6" first="23" last="23">
<title>Homozygous missense mutation (G56R) in glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 (GPI-HBP1) in two siblings with fasting chylomicronemia (MIM 144650).</title>
<authorList>
<person name="Wang J."/>
<person name="Hegele R.A."/>
</authorList>
<dbReference type="PubMed" id="17883852"/>
<dbReference type="DOI" id="10.1186/1476-511X-6-23"/>
</citation>
<scope>VARIANT ARG-56</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2009" name="Arterioscler. Thromb. Vasc. Biol." volume="29" first="956" last="962">
<title>Chylomicronemia with a mutant GPIHBP1 (Q115P) that cannot bind lipoprotein lipase.</title>
<authorList>
<person name="Beigneux A.P."/>
<person name="Franssen R."/>
<person name="Bensadoun A."/>
<person name="Gin P."/>
<person name="Melford K."/>
<person name="Peter J."/>
<person name="Walzem R.L."/>
<person name="Weinstein M.M."/>
<person name="Davies B.S.J."/>
<person name="Kuivenhoven J.A."/>
<person name="Kastelein J.J.P."/>
<person name="Fong L.G."/>
<person name="Dallinga-Thie G.M."/>
<person name="Young S.G."/>
</authorList>
<dbReference type="PubMed" id="19304573"/>
<dbReference type="DOI" id="10.1161/ATVBAHA.109.186577"/>
</citation>
<scope>VARIANT HLPP1D PRO-115</scope>
<scope>CHARACTERIZATION OF VARIANT HLPP1D PRO-115</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2010" name="J. Lipid Res." volume="51" first="1535" last="1545">
<title>Mutation of conserved cysteines in the Ly6 domain of GPIHBP1 in familial chylomicronemia.</title>
<authorList>
<person name="Olivecrona G."/>
<person name="Ehrenborg E."/>
<person name="Semb H."/>
<person name="Makoveichuk E."/>
<person name="Lindberg A."/>
<person name="Hayden M.R."/>
<person name="Gin P."/>
<person name="Davies B.S."/>
<person name="Weinstein M.M."/>
<person name="Fong L.G."/>
<person name="Beigneux A.P."/>
<person name="Young S.G."/>
<person name="Olivecrona T."/>
<person name="Hernell O."/>
</authorList>
<dbReference type="PubMed" id="20026666"/>
<dbReference type="DOI" id="10.1194/jlr.M002717"/>
</citation>
<scope>VARIANTS HLPP1D SER-65 AND GLY-68</scope>
<scope>CHARACTERIZATION OF VARIANTS HLPP1D SER-65 AND GLY-68</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2011" name="J. Clin. Endocrinol. Metab." volume="96" first="E1675" last="E1679">
<title>GPIHBP1 C89F neomutation and hydrophobic C-terminal domain G175R mutation in two pedigrees with severe hyperchylomicronemia.</title>
<authorList>
<person name="Charriere S."/>
<person name="Peretti N."/>
<person name="Bernard S."/>
<person name="Di Filippo M."/>
<person name="Sassolas A."/>
<person name="Merlin M."/>
<person name="Delay M."/>
<person name="Debard C."/>
<person name="Lefai E."/>
<person name="Lachaux A."/>
<person name="Moulin P."/>
<person name="Marcais C."/>
</authorList>
<dbReference type="PubMed" id="21816778"/>
<dbReference type="DOI" id="10.1210/jc.2011-1444"/>
</citation>
<scope>VARIANTS HLPP1D PHE-89 AND ARG-175</scope>
<scope>VARIANT PHE-14</scope>
<scope>CHARACTERIZATION OF VARIANTS HLPP1D PHE-89 AND ARG-175</scope>
<scope>CHARACTERIZATION OF VARIANT PHE-14</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2011" name="J. Intern. Med." volume="270" first="224" last="228">
<title>Childhood-onset chylomicronaemia with reduced plasma lipoprotein lipase activity and mass: identification of a novel GPIHBP1 mutation.</title>
<authorList>
<person name="Coca-Prieto I."/>
<person name="Kroupa O."/>
<person name="Gonzalez-Santos P."/>
<person name="Magne J."/>
<person name="Olivecrona G."/>
<person name="Ehrenborg E."/>
<person name="Valdivielso P."/>
</authorList>
<dbReference type="PubMed" id="21314738"/>
<dbReference type="DOI" id="10.1111/j.1365-2796.2011.02361.x"/>
</citation>
<scope>VARIANT HLPP1D TYR-68</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2012" name="J. Intern. Med." volume="272" first="185" last="196">
<title>Mutations in LPL, APOC2, APOA5, GPIHBP1 and LMF1 in patients with severe hypertriglyceridaemia.</title>
<authorList>
<person name="Surendran R.P."/>
<person name="Visser M.E."/>
<person name="Heemelaar S."/>
<person name="Wang J."/>
<person name="Peter J."/>
<person name="Defesche J.C."/>
<person name="Kuivenhoven J.A."/>
<person name="Hosseini M."/>
<person name="Peterfy M."/>
<person name="Kastelein J.J."/>
<person name="Johansen C.T."/>
<person name="Hegele R.A."/>
<person name="Stroes E.S."/>
<person name="Dallinga-Thie G.M."/>
</authorList>
<dbReference type="PubMed" id="22239554"/>
<dbReference type="DOI" id="10.1111/j.1365-2796.2012.02516.x"/>
</citation>
<scope>VARIANTS HLPP1D TYR-65; ARG-108; PRO-115 AND PHE-144</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2013" name="J. Atheroscler. Thromb." volume="20" first="777" last="784">
<title>Novel combined GPIHBP1 mutations in a patient with hypertriglyceridemia associated with CAD.</title>
<authorList>
<person name="Yamamoto H."/>
<person name="Onishi M."/>
<person name="Miyamoto N."/>
<person name="Oki R."/>
<person name="Ueda H."/>
<person name="Ishigami M."/>
<person name="Hiraoka H."/>
<person name="Matsuzawa Y."/>
<person name="Kihara S."/>
</authorList>
<dbReference type="PubMed" id="23831619"/>
<dbReference type="DOI" id="10.5551/jat.18861"/>
</citation>
<scope>VARIANT PHE-14</scope>
<scope>VARIANT HLPP1D ARG-68</scope>
<scope>CHARACTERIZATION OF VARIANT PHE-14</scope>
<scope>CHARACTERIZATION OF VARIANT HLPP1D ARG-68</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2015" name="Circ. Res." volume="116" first="624" last="632">
<title>GPIHBP1 missense mutations often cause multimerization of GPIHBP1 and thereby prevent lipoprotein lipase binding.</title>
<authorList>
<person name="Beigneux A.P."/>
<person name="Fong L.G."/>
<person name="Bensadoun A."/>
<person name="Davies B.S."/>
<person name="Oberer M."/>
<person name="Gaardsvoll H."/>
<person name="Ploug M."/>
<person name="Young S.G."/>
</authorList>
<dbReference type="PubMed" id="25387803"/>
<dbReference type="DOI" id="10.1161/CIRCRESAHA.116.305085"/>
</citation>
<scope>CHARACTERIZATION OF VARIANTS HLPP1D SER-65; TYR-65; ARG-68; GLY-68; TYR-68; PHE-89; ARG-108 AND PRO-115</scope>
<scope>SUBUNIT</scope>
<scope>INTERACTION WITH LPL</scope>
<scope>MUTAGENESIS OF TYR-66; LEU-71; THR-91; LEU-92; ILE-93; GLY-101; THR-104; THR-105; HIS-106; SER-107; THR-108; TRP-109; GLN-115 AND VAL-126</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2016" name="J. Clin. Lipidol." volume="10" first="915" last="921">
<title>Clinical and genetic features of 3 patients with familial chylomicronemia due to mutations in GPIHBP1 gene.</title>
<authorList>
<person name="Rabacchi C."/>
<person name="D'Addato S."/>
<person name="Palmisano S."/>
<person name="Lucchi T."/>
<person name="Bertolini S."/>
<person name="Calandra S."/>
<person name="Tarugi P."/>
</authorList>
<dbReference type="PubMed" id="27578123"/>
<dbReference type="DOI" id="10.1016/j.jacl.2016.03.009"/>
</citation>
<scope>VARIANT HLPP1D ARG-83</scope>
</reference>
<comment type="function">
<text evidence="1">Plays a key role in the lipolytic processing of chylomicrons. Required for the transport of lipoprotein lipase LPL into the capillary lumen (By similarity).</text>
</comment>
<comment type="subunit">
<text evidence="2 6 13">Mostly monomer, but also homodimer and homooligomer (PubMed:25387803). Interacts with high affinity with high-density lipoprotein (HDL) (By similarity). Only monomer interacts with lipoprotein lipase (LPL) (PubMed:25387803, PubMed:17997385). Interacts with chylomicrons and APOA5 (PubMed:17997385).</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="2">Apical cell membrane</location>
<topology evidence="2">Lipid-anchor</topology>
<topology evidence="2">GPI-anchor</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="2">Basolateral cell membrane</location>
<topology evidence="2">Lipid-anchor</topology>
<topology evidence="2">GPI-anchor</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="2">Cell membrane</location>
<topology evidence="2">Peripheral membrane protein</topology>
<orientation evidence="2">Extracellular side</orientation>
</subcellularLocation>
</comment>
<comment type="PTM">
<text evidence="1">Glycosylation of Asn-78 is critical for cell surface localization and the binding of chylomicrons and lipoprotein lipase.</text>
</comment>
<comment type="polymorphism">
<text>The missense variant Arg-56 may be associated with severe hypertriglyceridemia and chylomicronemia.</text>
</comment>
<comment type="disease" evidence="7 8 9 10 11 12 13 14">
<disease id="DI-04193">
<name>Hyperlipoproteinemia 1D</name>
<acronym>HLPP1D</acronym>
<description>An autosomal recessive disorder characterized by hyperlipoproteinemia, decreased plasma LPL levels in some patients, high plasma triglyceride levels, and refractory fasting chylomicronemia.</description>
<dbReference type="MIM" id="615947"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<dbReference type="EMBL" id="AY245915">
<property type="protein sequence ID" value="AAO86519.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471162">
<property type="protein sequence ID" value="EAW82276.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC035810">
<property type="protein sequence ID" value="AAH35810.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC063857">
<property type="protein sequence ID" value="AAH63857.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS34954.1"/>
<dbReference type="RefSeq" id="NP_001288701.1">
<property type="nucleotide sequence ID" value="NM_001301772.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_835466.2">
<property type="nucleotide sequence ID" value="NM_178172.5"/>
</dbReference>
<dbReference type="UniGene" id="Hs.426410"/>
<dbReference type="ProteinModelPortal" id="Q8IV16"/>
<dbReference type="BioGrid" id="130712">
<property type="interactions" value="6"/>
</dbReference>
<dbReference type="IntAct" id="Q8IV16">
<property type="interactions" value="1"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000329266"/>
<dbReference type="iPTMnet" id="Q8IV16"/>
<dbReference type="PhosphoSitePlus" id="Q8IV16"/>
<dbReference type="BioMuta" id="GPIHBP1"/>
<dbReference type="DMDM" id="74728020"/>
<dbReference type="PaxDb" id="Q8IV16"/>
<dbReference type="PeptideAtlas" id="Q8IV16"/>
<dbReference type="PRIDE" id="Q8IV16"/>
<dbReference type="DNASU" id="338328"/>
<dbReference type="Ensembl" id="ENST00000622500">
<property type="protein sequence ID" value="ENSP00000480053"/>
<property type="gene ID" value="ENSG00000277494"/>
</dbReference>
<dbReference type="GeneID" id="338328"/>
<dbReference type="KEGG" id="hsa:338328"/>
<dbReference type="UCSC" id="uc033cbs.1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="338328"/>
<dbReference type="DisGeNET" id="338328"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000277494.1"/>
<dbReference type="GeneCards" id="GPIHBP1"/>
<dbReference type="HGNC" id="HGNC:24945">
<property type="gene designation" value="GPIHBP1"/>
</dbReference>
<dbReference type="HPA" id="HPA066302"/>
<dbReference type="MalaCards" id="GPIHBP1"/>
<dbReference type="MIM" id="612757">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="615947">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q8IV16"/>
<dbReference type="Orphanet" id="411">
<property type="disease" value="Hyperlipoproteinemia type 1"/>
</dbReference>
<dbReference type="Orphanet" id="70470">
<property type="disease" value="Hyperlipoproteinemia type 5"/>
</dbReference>
<dbReference type="PharmGKB" id="PA162390135"/>
<dbReference type="eggNOG" id="ENOG410J46G">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG41116TR">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="HOGENOM" id="HOG000112872"/>
<dbReference type="InParanoid" id="Q8IV16"/>
<dbReference type="KO" id="K20001"/>
<dbReference type="OrthoDB" id="EOG091G0UW5"/>
<dbReference type="PhylomeDB" id="Q8IV16"/>
<dbReference type="TreeFam" id="TF338440"/>
<dbReference type="Reactome" id="R-HSA-163125">
<property type="pathway name" value="Post-translational modification: synthesis of GPI-anchored proteins"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8963889">
<property type="pathway name" value="Assembly of active LPL and LIPC lipase complexes"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8963901">
<property type="pathway name" value="Chylomicron remodeling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-975634">
<property type="pathway name" value="Retinoid metabolism and transport"/>
</dbReference>
<dbReference type="GenomeRNAi" id="338328"/>
<dbReference type="PRO" id="PR:Q8IV16"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 8"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000277494"/>
<dbReference type="CleanEx" id="HS_GPIHBP1"/>
<dbReference type="CleanEx" id="HS_HBP1"/>
<dbReference type="Genevisible" id="Q8IV16">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0031362">
<property type="term" value="C:anchored component of external side of plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0016324">
<property type="term" value="C:apical plasma membrane"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0016323">
<property type="term" value="C:basolateral plasma membrane"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0009897">
<property type="term" value="C:external side of plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005576">
<property type="term" value="C:extracellular region"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0034364">
<property type="term" value="C:high-density lipoprotein particle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0005622">
<property type="term" value="C:intracellular"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="GOC"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0035478">
<property type="term" value="F:chylomicron binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0035473">
<property type="term" value="F:lipase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008289">
<property type="term" value="F:lipid binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0071813">
<property type="term" value="F:lipoprotein particle binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008320">
<property type="term" value="F:protein transmembrane transporter activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006501">
<property type="term" value="P:C-terminal protein lipidation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0042632">
<property type="term" value="P:cholesterol homeostasis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0034371">
<property type="term" value="P:chylomicron remodeling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006886">
<property type="term" value="P:intracellular protein transport"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0090321">
<property type="term" value="P:positive regulation of chylomicron remnant clearance"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051006">
<property type="term" value="P:positive regulation of lipoprotein lipase activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0017038">
<property type="term" value="P:protein import"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0034394">
<property type="term" value="P:protein localization to cell surface"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0050821">
<property type="term" value="P:protein stabilization"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051004">
<property type="term" value="P:regulation of lipoprotein lipase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0071503">
<property type="term" value="P:response to heparin"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001523">
<property type="term" value="P:retinoid metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0045056">
<property type="term" value="P:transcytosis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0070328">
<property type="term" value="P:triglyceride homeostasis"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="InterPro" id="IPR016054">
<property type="entry name" value="LY6_UPA_recep-like"/>
</dbReference>
<dbReference type="Pfam" id="PF00021">
<property type="entry name" value="UPAR_LY6"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0336">GPI-anchor</keyword>
<keyword id="KW-0345">HDL</keyword>
<keyword id="KW-0446">Lipid-binding</keyword>
<keyword id="KW-0449">Lipoprotein</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0813">Transport</keyword>
<feature type="signal peptide" evidence="3">
<location>
<begin position="1"/>
<end position="20"/>
</location>
</feature>
<feature type="chain" description="Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1" id="PRO_0000318208">
<location>
<begin position="21"/>
<end position="151"/>
</location>
</feature>
<feature type="propeptide" description="Removed in mature form" id="PRO_0000429858" evidence="15">
<location>
<begin position="152"/>
<end position="184"/>
</location>
</feature>
<feature type="domain" description="UPAR/Ly6">
<location>
<begin position="63"/>
<end position="148"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Glu">
<location>
<begin position="25"/>
<end position="31"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Glu">
<location>
<begin position="40"/>
<end position="50"/>
</location>
</feature>
<feature type="lipid moiety-binding region" description="GPI-anchor amidated glycine" evidence="2">
<location>
<position position="151"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="78"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="65"/>
<end position="89"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="68"/>
<end position="77"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="83"/>
<end position="110"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="114"/>
<end position="130"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1">
<location>
<begin position="131"/>
<end position="136"/>
</location>
</feature>
<feature type="sequence variant" description="Polymorphism; it may act as a disease modifier contributing to severe HLPP1D when associated with R-68 or F-89; results in decreased GPIHBP1 expression at the cell surface; does not affect interaction with LPL when associated in cis with R-68 in one individual; dbSNP:rs11538389." id="VAR_044503" evidence="4 10 12">
<original>C</original>
<variation>F</variation>
<location>
<position position="14"/>
</location>
</feature>
<feature type="sequence variant" description="Polymorphism; no discernible effect on interaction with LPL, chylomicrons or APOA5; dbSNP:rs587777636." id="VAR_044504" evidence="5 6">
<original>G</original>
<variation>R</variation>
<location>
<position position="56"/>
</location>
</feature>
<feature type="sequence variant" description="In HLPP1D; does not affect protein expression at the cell surface; does not interact with LPL; promotes formation of dimers and oligomers severely reducing number of monomers; dbSNP:rs587777638." id="VAR_071881" evidence="8 13">
<original>C</original>
<variation>S</variation>
<location>
<position position="65"/>
</location>
</feature>
<feature type="sequence variant" description="In HLPP1D; does not interact with LPL; promotes formation of dimers and oligomers severely reducing number of monomers; dbSNP:rs587777638." id="VAR_077634" evidence="11 13">
<original>C</original>
<variation>Y</variation>
<location>
<position position="65"/>
</location>
</feature>
<feature type="sequence variant" description="In HLPP1D; does not affect protein expression at the cell surface; does not interact with LPL; promotes formation of dimers and oligomers reducing number of monomers; dbSNP:rs587777639." id="VAR_071882" evidence="8 13">
<original>C</original>
<variation>G</variation>
<location>
<position position="68"/>
</location>
</feature>
<feature type="sequence variant" description="In HLPP1D; unknown pathological significance; results in decreased GPIHBP1 expression; promotes formation of dimers and oligomers severely reducing number of monomers; does not affect interaction with LPL when associated in cis with F-14 in one individual." id="VAR_077635" evidence="12 13">
<original>C</original>
<variation>R</variation>
<location>
<position position="68"/>
</location>
</feature>
<feature type="sequence variant" description="In HLPP1D; does not interact with LPL; promotes formation of dimers and oligomers severely reducing number of monomers." id="VAR_077636" evidence="9 13">
<original>C</original>
<variation>Y</variation>
<location>
<position position="68"/>
</location>
</feature>
<feature type="sequence variant" description="In HLPP1D." id="VAR_077637" evidence="14">
<original>C</original>
<variation>R</variation>
<location>
<position position="83"/>
</location>
</feature>
<feature type="sequence variant" description="In HLPP1D; drastically affects interaction with LPL; promotes formation of dimers and oligomers reducing number of monomers; dbSNP:rs587777640." id="VAR_071883" evidence="10 13">
<original>C</original>
<variation>F</variation>
<location>
<position position="89"/>
</location>
</feature>
<feature type="sequence variant" description="In HLPP1D; does not interact with LPL; promotes formation of dimers and oligomers reducing number of monomers." id="VAR_077638" evidence="11 13">
<original>T</original>
<variation>R</variation>
<location>
<position position="108"/>
</location>
</feature>
<feature type="sequence variant" description="In HLPP1D; a patient with chylomicronemia; does not affect protein expression at the cell surface; does not interact with LPL; does not interact with chylomicrons; promotes formation of dimers and oligomers reducing number of monomers; dbSNP:rs587777637." id="VAR_058086" evidence="7 11 13">
<original>Q</original>
<variation>P</variation>
<location>
<position position="115"/>
</location>
</feature>
<feature type="sequence variant" description="In HLPP1D; dbSNP:rs78367243." id="VAR_077639" evidence="11">
<original>S</original>
<variation>F</variation>
<location>
<position position="144"/>
</location>
</feature>
<feature type="sequence variant" description="In HLPP1D; affects protein expression at the cell surface; reduces interaction with LPL; dbSNP:rs145844329." id="VAR_071884" evidence="10">
<original>G</original>
<variation>R</variation>
<location>
<position position="175"/>
</location>
</feature>
<feature type="mutagenesis site" description="Promotes formation of dimers and oligomers reducing number of monomers." evidence="13">
<original>Y</original>
<variation>A</variation>
<location>
<position position="66"/>
</location>
</feature>
<feature type="mutagenesis site" description="Promotes formation of dimers and oligomers reducing number of monomers." evidence="13">
<original>L</original>
<variation>A</variation>
<location>
<position position="71"/>
</location>
</feature>
<feature type="mutagenesis site" description="Promotes formation of dimers and oligomers reducing number of monomers." evidence="13">
<original>T</original>
<variation>A</variation>
<location>
<position position="91"/>
</location>
</feature>
<feature type="mutagenesis site" description="Only slightly increased formation of dimers and oligomers. No effect on number of monomers. Loss of LPL interaction." evidence="13">
<original>L</original>
<variation>A</variation>
<location>
<position position="92"/>
</location>
</feature>
<feature type="mutagenesis site" description="Promotes formation of dimers and oligomers reducing number of monomers." evidence="13">
<original>I</original>
<variation>A</variation>
<location>
<position position="93"/>
</location>
</feature>
<feature type="mutagenesis site" description="Promotes formation of dimers and oligomers reducing number of monomers. Retained some interaction with LPL." evidence="13">
<original>G</original>
<variation>S</variation>
<location>
<position position="101"/>
</location>
</feature>
<feature type="mutagenesis site" description="Promotes formation of dimers and oligomers reducing number of monomers. Retained some interaction with LPL." evidence="13">
<original>T</original>
<variation>A</variation>
<location>
<position position="104"/>
</location>
</feature>
<feature type="mutagenesis site" description="Promotes formation of dimers and oligomers reducing number of monomers." evidence="13">
<original>T</original>
<variation>A</variation>
<location>
<position position="105"/>
</location>
</feature>
<feature type="mutagenesis site" description="Promotes formation of dimers and oligomers severely reducing number of monomers." evidence="13">
<original>H</original>
<variation>L</variation>
<location>
<position position="106"/>
</location>
</feature>
<feature type="mutagenesis site" description="Promotes formation of dimers and oligomers reducing number of monomers." evidence="13">
<original>S</original>
<variation>A</variation>
<location>
<position position="107"/>
</location>
</feature>
<feature type="mutagenesis site" description="Retained some interaction with LPL. No effect on number of monomers." evidence="13">
<original>T</original>
<variation>A</variation>
<location>
<position position="108"/>
</location>
</feature>
<feature type="mutagenesis site" description="Promotes formation of dimers and oligomers reducing number of monomers. Loss of LPL interaction." evidence="13">
<original>W</original>
<variation>C</variation>
<variation>P</variation>
<variation>T</variation>
<location>
<position position="109"/>
</location>
</feature>
<feature type="mutagenesis site" description="Only slightly increased formation of dimers and oligomers. No effect on number of monomers. Loss of LPL interaction." evidence="13">
<original>W</original>
<variation>S</variation>
<variation>Y</variation>
<variation>H</variation>
<variation>A</variation>
<variation>F</variation>
<location>
<position position="109"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on number of monomers." evidence="13">
<original>Q</original>
<variation>K</variation>
<location>
<position position="115"/>
</location>
</feature>
<feature type="mutagenesis site" description="Promotes formation of dimers and oligomers reducing number of monomers." evidence="13">
<original>V</original>
<variation>A</variation>
<location>
<position position="126"/>
</location>
</feature>
<evidence key="1" type="ECO:0000250"/>
<evidence key="2" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9D1N2"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000255"/>
<evidence key="4" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17883852"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17997385"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19304573"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20026666"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21314738"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21816778"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22239554"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23831619"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25387803"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27578123"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000305"/>
<sequence length="184" mass="19806" checksum="89FF61B08A008C70" modified="2004-12-07" version="2" precursor="true">
MKALGAVLLALLLCGRPGRGQTQQEEEEEDEDHGPDDYDEEDEDEVEEEETNRLPGGRSR
VLLRCYTCKSLPRDERCNLTQNCSHGQTCTTLIAHGNTESGLLTTHSTWCTDSCQPITKT
VEGTQVTMTCCQSSLCNVPPWQSSRVQDPTGKGAGGPRGSSETVGAALLLNLLAGLGAMG
ARRP
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>